Drug interactions
Imatinib + Sipuleucel-t
Severity: Minor
Imatinib and Sipuleucel-t: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Sipuleucel-T depends on the patient's own immune cells being activated. Imatinib's kinase inhibition and cytopenic effects could theoretically blunt this immune response, though clinical data are lacking.
What this interaction means in plain words
Imatinib and Sipuleucel-t have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Theoretical pharmacodynamic antagonism; not well established.
What to do
Review the timing of imatinib around leukapheresis and infusion with the oncology team. Monitor the clinical response to treatment.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Sipuleucel-t, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Imatinib
- Imatinib + Lomitapide Contraindicated
- Imatinib + Lonafarnib Contraindicated
- Amobarbital + Imatinib Major
- Apalutamide + Imatinib Major
- Avapritinib + Imatinib Major
- Benzhydrocodone / acetaminophen + Imatinib Major
Frequently asked questions
Can I take Imatinib with Sipuleucel-t?
MediHelp rates the interaction as minor. Imatinib and Sipuleucel-t have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Sipuleucel-T depends on the patient's own immune cells being activated. Imatinib's kinase inhibition and cytopenic effects could theoretically blunt this immune response, though clinical data are lacking.
How serious is the interaction between Imatinib and Sipuleucel-t?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Review the timing of imatinib around leukapheresis and infusion with the oncology team. Monitor the clinical response to treatment.
What other medicines interact with Imatinib?
MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
